• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Aytu Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline

    ACCESWIRE

    Aytu BioPharma Divests U.S. Rights to Natesto(R) to Acerus Pharma

    ACCESSWIRE

    Aytu BioScience Announces Close of Merger with Neos Therapeutics

    BIOSPACE

    Aytu BioScience Announces Close of Merger with Neos Therapeutics

    BIOSPACE

    Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders

    BIOSPACE

    Aytu BioScience Announces Closing of $28.75 Million Bought Deal Offering

    BIOSPACE

    Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement

    GLOBENEWSWIRE

    Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement,

    GLOBENEWSWIRE

    Aytu BioScience Announces $10.0 Million Bought Deal Offering

    ACCESSWIRE

    Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian

    BIOSPACE

    Aytu BioScience Announces Exclusive ZolpiMist(TM) License Aytu`s Oral Spray

    MARKETWATCH

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.